共 50 条
- [2] Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed and refractory multiple myeloma: real-world experience [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S2 - S3
- [4] Chimeric antigen receptor T-cell therapy: a promising treatment modality for relapsed/refractory mantle cell lymphoma [J]. Frontiers of Medicine, 2020, 14 : 811 - 815
- [7] Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center [J]. Bone Marrow Transplantation, 2022, 57 : 1025 - 1027
- [9] Real-World Experience and Optimization of Outpatient Chimeric Antigen Receptor T Cell Therapy [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (09): : 583 - 585